http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201790603-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-54
filingDate 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201790603-A1
titleOfInvention Inhibitors of histonedehylase
abstract The invention relates generally to compositions and methods for the treatment of cancer and neoplastic disease. This document provides compounds of substituted pyrido [3,4-d] pyrimidin-4-one derivatives and pharmaceutical compositions containing these compounds. The claimed compounds and compositions are useful for inhibiting histonemethylase. In addition, the claimed compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and / or melanoma, etc.
priorityDate 2014-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135567106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414040879

Total number of triples: 15.